Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis
Year: 2026
Type: article
Study design: Study Protocol
Source: Journal of Nuclear Cardiology
Authors: Sharmila Dorbala, Mathew S. Maurer, Sarah A.M. Cuddy, Benjamin D. Auer, Marie Foley Kijewski, Olivier F. Clerc, Michel G. Khouri, Joshua D. Mitchell, Brett W. Sperry, Mazen Hanna, Omar F. AbouEzzeddine, Saurabh Malhotra, Jonathan S. Wall, Spencer Guthrie, Marcelo F. Di Carli, Frederick L. Ruberg, Vasken Dilsizian, Angela Dispenzieri, James E. Udelson, Ravi K. Narra, Ahmad M. Masri
Institutions: Brigham and Women's Hospital, Columbia University, Duke University Health System, Washington University in St. Louis, Cleveland Clinic, Mayo Clinic, Cook County Health and Hospitals System, University of Tennessee at Knoxville, Bayer (Germany), Boston University, Boston Medical Center, University of Maryland, Baltimore, Tufts Medical Center, Medical College of Wisconsin, Oregon Health & Science University
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bayer
OpenAlex ID: W7164835713